Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Option exercise Director acquired 2,137 shares (option exercise)
  5. 4 Grant or award Director acquired 428 shares (grant or award)
  6. 4 Grant or award Director acquired 199 shares (grant or award)
  7. 4 Grant or award Director acquired 657 shares (grant or award)
  8. 4 Grant or award Director acquired 318 shares (grant or award)
  9. 4 Grant or award Director acquired 278 shares (grant or award)
  10. 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $31.66 ($474,968)
  11. 4 Option exercise Chief Medical Officer acquired 5,000 shares (option exercise)
  12. 4 Open-market sale Director sold 755 shares at $30.25 ($22,839)
  13. 4 Option exercise Chief Scientific Officer acquired 20,562 shares (option exercise)
  14. 4 Open-market sale Director sold 755 shares at $40.11 ($30,283)
  15. 4 Open-market sale Director sold 755 shares at $44.94 ($33,930)
  16. 4 Option exercise Chief Medical Officer acquired 10,000 shares (option exercise)
  17. 4 Grant or award Director acquired 300 shares (grant or award)
  18. 4 Grant or award Director acquired 138 shares (grant or award)
  19. 4 Grant or award Director acquired 461 shares (grant or award)
  20. 4 Grant or award Director acquired 222 shares (grant or award)

Page 11 of 15 · 296 filings